OSD and Injectable Oncology - Verna, Goa - Installation completed and under process validation
OSD - Skidel, Belarus Inaugurated on 7-Mar-19. Commercial Licence Obtained in Dec-2019
ONCO API, Goa - Building is ready, machine installations in progress
Face mask, Two Yard distance and hand wash is must
R&D and ADL centre has certified by DSIR, Govt. of India.
Launch of two products in our brand and for contract manufacturing Oseltamavir caps, 30mg, 45mg and 75 mg And Favipiravir 200 mg/400mg/800mg Tablet.
Today Lok-Beta is a key player in the Indian market, with a wide range of products in various segments such as Anti-Inflammatory, Antibiotics, Anti-Histaminics, Antitussive and planning to enter in new segment Neutraceuticals, Antimalarial, Antihypertensive and Anti-Diabetic, Gastroenterology.
Fight against Novel Coronavirus ( COVID-19)
LOPIRAVIR - 250 mg / 125 mg (Lopinavir 200 mg & Ritonavir 50mg) Manufactured by J Duncan Healthcare Pvt. Ltd, Marketed by LOK-BETA Pharmaceuticals (I) Pvt. Ltd.
TINAROVIR - 125 mg (Lopinavir 200 mg & Ritonavir 50mg) Marketed and Manufactured by LOK-BETA Pharmaceuticals (I) Pvt. Ltd.
Lok-Beta enjoys a strong rapport with the medical profession including specialist, who have accepted Lok-Beta's product for their High quality, efficacy and affordability. Lok-Beta has a strong presence with its own team in the states of UP, Jharkhand, Bihar and Maharashtra aiming to penetrate PAN India market.
The majority of products marketed are for the treatment and/or prevention of chronic and recurrent illness. Lok-Beta concentrates on the following therapeutic area with niche molecules.